(Q42479564)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

21 October 2019

main subject

1 reference

1 reference

2

A. Cagnacci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

author name string

A. M. Paoletti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

R. Soldani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

M. Orrù

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

S. Ajossa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

G. Pittorra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

P. Mulas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

G. B. Melis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

28 May 2024

language of work or name

English

0 references

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

https://doi.org/10.1016/s0015-0282(16)57966-7

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589658

https://api.elsevier.com/content/article/PII:S0015028216579667?httpAccept=text/xml

28 May 2024

1 reference

10.1016/S0015-0282(16)57966-7

DOI

https://api.crossref.org/works/10.1016/S0015-0282(16)57966-7

https://api.elsevier.com/content/article/PII:S0015028216579667?httpAccept=text/plain

28 May 2024

1 reference

10.1016/S0015-0282(16)57966-7

DOI

https://api.crossref.org/works/10.1016/S0015-0282(16)57966-7

28 May 2024

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1094-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

Polycystic ovarian disease: a challenge and controversy

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Hyperprolactinemia in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Prolactin secretion in polycystic ovary syndrome (PCO): correlation with the steroid pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Evidence for a hypothalamic alteration of catecholamine metabolism in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Autoradiographic identification of prolactin binding sites in rat median eminence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Estrogen and progestin receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Domperidone: a novel agent for the investigation of anterior pituitary function and control in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Polycystic ovarian disease associated with hyperprolactinemia and defective metoclopramide response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Prolactin-releasing action of a low dose of exogenous gonadotropin-releasing hormone throughout the human menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Effects of dopamine and metoclopramide in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Granulosa cells of polycystic ovaries: are they normal or abnormal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957966-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)57966-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589658%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference